Methods for determining whether an ADHD patient is suitable for treatment with a monoamine oxidase type B (MAO-B) inhibitor, and uses of MAO-B inhibitors in medicaments for treatment of ADHD. Nucleic acid probes and primer sequences useful for determining MAO-B activity in ADHD patients.